Glycation potentiates neurodegeneration in models of Huntington's disease. (2016)
Attributed to:
CHARACTERISING KYNURENINE 3-MONOOXYGENASE (KMO) AS A THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/srep36798
PubMed Identifier: 27857176
Publication URI: http://europepmc.org/abstract/MED/27857176
Type: Journal Article/Review
Volume: 6
Parent Publication: Scientific reports
ISSN: 2045-2322